HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Gene Therapy & RNA Therapeutics

Gene Therapy & RNA Therapeutics

Gene Therapy & RNA Therapeutics are redefining the future of disease treatment by targeting conditions at their genetic root. Gene therapy introduces functional genes into patients' cells to correct genetic mutations, using viral or non-viral vectors to deliver therapeutic DNA. Simultaneously, RNA-based drugs—such as siRNA, mRNA, and antisense oligonucleotides—are being used to silence, replace, or modulate gene expression with high specificity. Recent advances include mRNA vaccines and gene-editing platforms like CRISPR for correcting single-gene disorders. Gene Therapy & RNA Therapeutics are proving effective against cancer, rare genetic diseases, and neurodegenerative disorders. As delivery mechanisms and regulatory frameworks evolve, these molecular approaches are becoming more accessible and personalized, with potential to revolutionize preventive, curative, and precision medicine.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Tags

Submit your abstract Today

Watsapp